PRKAA2 and diabetic kidney disease: Recent study have demonstrated that enhancing SIRT1 antagonizes oxidative stress in the pathogenesis of diabetic kidney disease and that AMPK is an critical mediator that regulates SIRT1-mediated oxidative stress reduction [23,34–37].